| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 15 | 2024 | 538 | 3.040 |
Why?
|
| STAT3 Transcription Factor | 8 | 2021 | 221 | 1.930 |
Why?
|
| STAT5 Transcription Factor | 3 | 2021 | 90 | 1.170 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 4 | 2021 | 96 | 0.970 |
Why?
|
| Apoptosis | 8 | 2020 | 1789 | 0.800 |
Why?
|
| Antineoplastic Agents | 7 | 2023 | 1674 | 0.760 |
Why?
|
| Interleukin-10 | 1 | 2022 | 173 | 0.730 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 316 | 0.650 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2024 | 66 | 0.620 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 467 | 0.600 |
Why?
|
| Gene Rearrangement | 3 | 2016 | 320 | 0.530 |
Why?
|
| Transcriptome | 3 | 2021 | 937 | 0.520 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2015 | 5 | 0.490 |
Why?
|
| Mitoxantrone | 1 | 2015 | 26 | 0.490 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 722 | 0.490 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 578 | 0.470 |
Why?
|
| Methyltransferases | 2 | 2016 | 71 | 0.470 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2015 | 211 | 0.450 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 554 | 0.390 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2023 | 98 | 0.370 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 669 | 0.360 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 3341 | 0.320 |
Why?
|
| Signal Transduction | 4 | 2019 | 4534 | 0.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 672 | 0.310 |
Why?
|
| Receptors, Opioid, kappa | 6 | 2000 | 22 | 0.300 |
Why?
|
| Naphthalenes | 2 | 2020 | 37 | 0.300 |
Why?
|
| Recurrence | 2 | 2022 | 1423 | 0.290 |
Why?
|
| Myelopoiesis | 1 | 2007 | 13 | 0.290 |
Why?
|
| Child, Preschool | 12 | 2024 | 14085 | 0.280 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2024 | 158 | 0.270 |
Why?
|
| Child | 16 | 2024 | 24528 | 0.270 |
Why?
|
| Myeloid Cells | 1 | 2007 | 100 | 0.270 |
Why?
|
| Infant | 10 | 2024 | 12481 | 0.270 |
Why?
|
| Interleukin-6 | 2 | 2022 | 415 | 0.260 |
Why?
|
| Sulfonamides | 2 | 2020 | 261 | 0.260 |
Why?
|
| Up-Regulation | 2 | 2021 | 862 | 0.250 |
Why?
|
| Hippocampus | 7 | 1996 | 830 | 0.250 |
Why?
|
| Adolescent | 13 | 2024 | 19358 | 0.250 |
Why?
|
| Neutrophils | 1 | 2007 | 378 | 0.240 |
Why?
|
| Candida tropicalis | 1 | 2024 | 16 | 0.230 |
Why?
|
| Candidiasis, Invasive | 1 | 2024 | 19 | 0.230 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2018 | 212 | 0.220 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2023 | 11 | 0.220 |
Why?
|
| Translocation, Genetic | 2 | 2018 | 356 | 0.220 |
Why?
|
| Prognosis | 5 | 2024 | 4554 | 0.220 |
Why?
|
| Immunophenotyping | 1 | 2024 | 329 | 0.220 |
Why?
|
| Benzeneacetamides | 3 | 2000 | 8 | 0.210 |
Why?
|
| Quinolines | 1 | 2023 | 96 | 0.210 |
Why?
|
| Antifungal Agents | 1 | 2024 | 289 | 0.190 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 274 | 0.190 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2018 | 64 | 0.190 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1930 | 0.190 |
Why?
|
| Hematologic Neoplasms | 1 | 2024 | 286 | 0.180 |
Why?
|
| Culture Media, Conditioned | 1 | 2021 | 80 | 0.180 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 66 | 0.180 |
Why?
|
| Cryopreservation | 1 | 2021 | 73 | 0.180 |
Why?
|
| Interleukin-13 | 1 | 2021 | 97 | 0.180 |
Why?
|
| Humans | 26 | 2024 | 124398 | 0.170 |
Why?
|
| Male | 22 | 2024 | 61025 | 0.170 |
Why?
|
| Atovaquone | 1 | 2019 | 8 | 0.170 |
Why?
|
| Dentate Gyrus | 3 | 2000 | 54 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2023 | 530 | 0.170 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 1320 | 0.170 |
Why?
|
| Pyrrolidines | 3 | 2000 | 36 | 0.170 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 12 | 0.170 |
Why?
|
| Interleukin-15 | 1 | 2020 | 91 | 0.170 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 107 | 0.160 |
Why?
|
| Guinea Pigs | 7 | 2000 | 166 | 0.160 |
Why?
|
| Transcriptional Activation | 1 | 2021 | 483 | 0.160 |
Why?
|
| Cytokines | 2 | 2022 | 1279 | 0.150 |
Why?
|
| Dihydroergotamine | 1 | 2018 | 10 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 375 | 0.150 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2018 | 33 | 0.150 |
Why?
|
| Phosphorylation | 2 | 2012 | 1625 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2018 | 78 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2018 | 86 | 0.150 |
Why?
|
| Long-Term Potentiation | 3 | 2000 | 164 | 0.150 |
Why?
|
| Mice, Inbred NOD | 4 | 2020 | 285 | 0.140 |
Why?
|
| Female | 14 | 2024 | 66305 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 1417 | 0.140 |
Why?
|
| Dynorphins | 3 | 2000 | 9 | 0.140 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 136 | 0.140 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 548 | 0.140 |
Why?
|
| Animals | 22 | 2020 | 34139 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 185 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2024 | 802 | 0.140 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2016 | 8 | 0.130 |
Why?
|
| Rhodium | 1 | 2015 | 4 | 0.130 |
Why?
|
| Histone Demethylases | 1 | 2016 | 38 | 0.130 |
Why?
|
| Cell Proliferation | 5 | 2018 | 2304 | 0.130 |
Why?
|
| Ikaros Transcription Factor | 1 | 2015 | 28 | 0.120 |
Why?
|
| Syk Kinase | 1 | 2015 | 12 | 0.120 |
Why?
|
| Cell Survival | 3 | 2019 | 806 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2018 | 384 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 1199 | 0.120 |
Why?
|
| Young Adult | 3 | 2021 | 8979 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2016 | 1108 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 860 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 887 | 0.120 |
Why?
|
| Synapses | 2 | 2000 | 460 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2005 | 2607 | 0.120 |
Why?
|
| HL-60 Cells | 1 | 2014 | 32 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1695 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 1064 | 0.110 |
Why?
|
| Histones | 2 | 2016 | 534 | 0.110 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2014 | 24 | 0.110 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 823 | 0.110 |
Why?
|
| Synaptic Transmission | 2 | 1997 | 351 | 0.110 |
Why?
|
| Neural Inhibition | 2 | 1994 | 108 | 0.110 |
Why?
|
| Endorphins | 2 | 1994 | 7 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2015 | 299 | 0.110 |
Why?
|
| Mice | 10 | 2020 | 17725 | 0.110 |
Why?
|
| Filgrastim | 1 | 2012 | 15 | 0.100 |
Why?
|
| Leukemia | 1 | 2016 | 376 | 0.100 |
Why?
|
| Intestinal Perforation | 1 | 2013 | 60 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 1288 | 0.100 |
Why?
|
| Cell Separation | 1 | 2012 | 229 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2018 | 571 | 0.100 |
Why?
|
| Radiation Dosage | 1 | 2012 | 135 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2014 | 616 | 0.090 |
Why?
|
| Burkitt Lymphoma | 1 | 2013 | 146 | 0.090 |
Why?
|
| Immunotherapy | 1 | 2016 | 662 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 546 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 719 | 0.090 |
Why?
|
| DNA Damage | 1 | 2014 | 514 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1899 | 0.090 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 298 | 0.090 |
Why?
|
| Nerve Fibers | 2 | 2000 | 72 | 0.090 |
Why?
|
| Ligands | 1 | 2011 | 535 | 0.080 |
Why?
|
| Hodgkin Disease | 1 | 2012 | 293 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2007 | 412 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 1392 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2012 | 1482 | 0.080 |
Why?
|
| Axons | 3 | 2000 | 393 | 0.080 |
Why?
|
| Neurons | 3 | 2000 | 1964 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 810 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 94 | 0.070 |
Why?
|
| Dendrites | 2 | 2000 | 204 | 0.070 |
Why?
|
| Pilocarpine | 1 | 1997 | 12 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1697 | 0.070 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 213 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 568 | 0.070 |
Why?
|
| Elapid Venoms | 1 | 1996 | 8 | 0.070 |
Why?
|
| Adult | 3 | 2023 | 29396 | 0.070 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1997 | 88 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 4355 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2007 | 177 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 1996 | 76 | 0.060 |
Why?
|
| Potassium Channels | 1 | 1996 | 157 | 0.060 |
Why?
|
| Cell Line | 2 | 2007 | 2770 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2005 | 19 | 0.060 |
Why?
|
| Risk Factors | 2 | 2024 | 10149 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2007 | 677 | 0.060 |
Why?
|
| Adenylyl Cyclases | 1 | 1995 | 75 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 292 | 0.060 |
Why?
|
| Drug Resistance, Fungal | 1 | 2024 | 24 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 98 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2824 | 0.060 |
Why?
|
| Milk Proteins | 1 | 2005 | 92 | 0.060 |
Why?
|
| Calcium Channels | 1 | 1995 | 159 | 0.060 |
Why?
|
| Granulocytes | 1 | 1994 | 66 | 0.060 |
Why?
|
| Karyotyping | 2 | 2015 | 330 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2088 | 0.060 |
Why?
|
| Aniline Compounds | 1 | 2023 | 19 | 0.060 |
Why?
|
| Drug Design | 1 | 2005 | 146 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 1994 | 144 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 1994 | 200 | 0.050 |
Why?
|
| Nitriles | 1 | 2023 | 146 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 764 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2005 | 459 | 0.050 |
Why?
|
| Norepinephrine | 1 | 1992 | 173 | 0.050 |
Why?
|
| Analgesics | 3 | 2000 | 135 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 786 | 0.050 |
Why?
|
| Learning | 1 | 1995 | 363 | 0.050 |
Why?
|
| In Vitro Techniques | 3 | 2000 | 969 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 1991 | 75 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2005 | 807 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 1991 | 124 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 35 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 820 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 445 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 183 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 1272 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8185 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1687 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 353 | 0.040 |
Why?
|
| Brain | 2 | 1995 | 3003 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 122 | 0.040 |
Why?
|
| Incidence | 1 | 2024 | 3086 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1074 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2024 | 16234 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2018 | 276 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2016 | 37 | 0.030 |
Why?
|
| Kinetics | 3 | 2007 | 1321 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 2055 | 0.030 |
Why?
|
| U937 Cells | 1 | 2016 | 25 | 0.030 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2016 | 11 | 0.030 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2016 | 49 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2016 | 58 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2016 | 84 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1747 | 0.030 |
Why?
|
| Retroviridae | 1 | 2016 | 196 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 300 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 232 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 224 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 222 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 211 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 126 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2016 | 262 | 0.030 |
Why?
|
| Rituximab | 1 | 2016 | 156 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 286 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 290 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 198 | 0.030 |
Why?
|
| Evoked Potentials | 2 | 1996 | 145 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1996 | 395 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1991 | 1015 | 0.030 |
Why?
|
| Leukocytosis | 1 | 2014 | 45 | 0.030 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2014 | 67 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 1996 | 202 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 675 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 528 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2014 | 160 | 0.030 |
Why?
|
| Binding Sites | 1 | 2015 | 1294 | 0.030 |
Why?
|
| DNA | 1 | 2018 | 1598 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2016 | 940 | 0.020 |
Why?
|
| Peptides | 2 | 1996 | 793 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1264 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 1015 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 543 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3753 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 370 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 510 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 1996 | 1684 | 0.020 |
Why?
|
| Dipeptidases | 1 | 1990 | 14 | 0.020 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2000 | 14 | 0.020 |
Why?
|
| Rats | 3 | 1997 | 3687 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 59 | 0.020 |
Why?
|
| Calcium | 2 | 1995 | 1095 | 0.020 |
Why?
|
| Mutation | 2 | 2015 | 5809 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1894 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 12287 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 135 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 233 | 0.020 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1996 | 6 | 0.020 |
Why?
|
| Bee Venoms | 1 | 1996 | 7 | 0.020 |
Why?
|
| Nerve Endings | 1 | 1996 | 8 | 0.020 |
Why?
|
| Tetraethylammonium | 1 | 1996 | 9 | 0.020 |
Why?
|
| 4-Aminopyridine | 1 | 1996 | 32 | 0.020 |
Why?
|
| Barium | 1 | 1996 | 17 | 0.020 |
Why?
|
| Glyburide | 1 | 1996 | 22 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1996 | 125 | 0.020 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 1996 | 31 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 391 | 0.020 |
Why?
|
| Neurotoxins | 1 | 1996 | 56 | 0.020 |
Why?
|
| omega-Conotoxin GVIA | 1 | 1995 | 7 | 0.020 |
Why?
|
| Isradipine | 1 | 1995 | 7 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 755 | 0.020 |
Why?
|
| Nifedipine | 1 | 1995 | 20 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1995 | 113 | 0.020 |
Why?
|
| Genomic Library | 1 | 1995 | 39 | 0.020 |
Why?
|
| Naltrexone | 1 | 1995 | 69 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1995 | 74 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1995 | 188 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 1994 | 21 | 0.010 |
Why?
|
| Autoradiography | 1 | 1994 | 71 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1994 | 90 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1994 | 55 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 1228 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1996 | 816 | 0.010 |
Why?
|
| Oocytes | 1 | 1996 | 284 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1995 | 248 | 0.010 |
Why?
|
| Brain Stem | 1 | 1995 | 115 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1994 | 386 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2007 | 889 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1992 | 25 | 0.010 |
Why?
|
| Naloxone | 1 | 1992 | 47 | 0.010 |
Why?
|
| Propranolol | 1 | 1992 | 129 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 455 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1992 | 323 | 0.010 |
Why?
|
| Cerebellum | 1 | 1995 | 416 | 0.010 |
Why?
|
| Dipeptides | 1 | 1991 | 59 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1991 | 260 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1991 | 193 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1991 | 302 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1995 | 3050 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1991 | 1006 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 26459 | 0.010 |
Why?
|
| Time Factors | 1 | 1994 | 6272 | 0.010 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 1990 | 6 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1990 | 68 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 70 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 96 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1990 | 65 | 0.010 |
Why?
|
| Synaptosomes | 1 | 1990 | 31 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1990 | 63 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1990 | 392 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 314 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1990 | 426 | 0.010 |
Why?
|